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Objectives: This study aimed to test the hypothesis that sleep and depression have independent effects
on brain development and plasticity in adolescents, and that these changes are reﬂected in changes in
the epigenome.
Methods: Participants were 17 medication-free adolescent boys (age 16.05 ± 0.80 years, mean ± standard
deviation (SD); eight cases with depression and sleep symptoms, nine healthy controls). Sleep was
assessed by polysomnography recordings and the Pediatric Daytime Sleepiness Scale (PDSS) and Athens
Insomnia Scale (AIS). Participants underwent a clinical evaluation. DNA methylation of blood leukocytes
was measured by Illumina 450K array, and Ingenuity Pathway analysis was applied to identify the most
signiﬁcant pathways with differentially methylated positions (DMPs). Secondary analysis of the identi-
ﬁed loci included linear correlations between methylation and the subjectively rated scales of sleep,
depression and sleep microarchitecture.
Results: Due to small sample size, we found no genome-wide signiﬁcant differences in methylation
between cases and controls. However, pathway analysis identiﬁed the synaptic long-term depression
(LTD) canonical pathway (p ¼ 0.00045) when the best 500 DMPs from the original caseecontrol design
were included. A ﬂattened dissipation of slow wave sleep, tiredness and depression severity values
correlated with ﬁve of 10 sites from the LTD pathway (IGF1R, PLAG16, PLA2R1, PPP2C5 and ERK12) in the
secondary analysis when the caseecontrol status was controlled for.
Conclusion: Among adolescents, depressive disorder with sleep symptoms is associated with a distinc-
tive epigenetic pattern of DNA methylation in blood leukocytes. The enrichment of DMPs on genes
related to synaptic LTD emphasizes the role of sleep in synaptic plasticity and the widespread physio-
logical consequences of disturbed sleep.
© 2019 Elsevier B.V. All rights reserved.Health and Welfare, Man-
m€al€a).
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Adolescence is characterized bymajor changes in sleep patterns.
Despite being a period of rapid increases in physical and mental
capabilities, it is paradoxically also a period of augmented vulner-
ability to psychiatric and sleep disorders, and the incidence of both
insomnia and major depression increases simultaneously during
adolescence [1].nes related to synaptic long-term depression among adolescents with
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and share many common features as well as common mechanisms
[2,3]. Disordered sleep also increases the risk of depression [4,5].
The majority of patients with depressive disorder have symptoms
of disturbed sleep (insomnia or hypersomnia), which also belong to
the diagnostic criteria of the disorder [6]. Further, disturbances in
cognitive functions are common to both conditions. A diminished
ability to think or concentrate are hallmarks of clinical depression
[6], while sleep deprivation and chronic sleep disturbance lead to
reduced attention and vigilance, as well as impairments in memory
and learning. Information acquisition takes place during waking,
most effectively during high vigilance, while sleep promotes
memory consolidation. The cellular mechanisms for memory for-
mation comprise the activity-dependent plasticity processes of
long-term potentiation (LTP) and long-term depression (LTD). They
involve a number of biological processes ranging from changes in
gene expression to synthesis of new proteins and comprising
hundreds of molecules and molecular pathways [7]. Sleep depri-
vation, on the other hand, may impact structural plasticity via
synaptic downscaling or by reducing spine density and attenuating
synaptic efﬁcacy in the hippocampus [8], whichmight be one of the
cellular mechanisms linking depression, disturbed sleep and
cognitive functions [9,10].
Similarities between depression and disturbed sleep extend
beyond signs and symptoms from the brain. Both conditions co-
occur with low-level systemic inﬂammatory reactions and corre-
sponding changes in gene expression in cells of the immune sys-
tem, including blood leukocytes [11,12]. They are also frequently
comorbid with other medical conditions associated with systemic
inﬂammation, such as obesity or metabolic syndrome [13,14]. Thus,
despite a neural origin, depression and insufﬁcient sleep can be
considered systemic disorders affecting functions of the whole
body.
Insomnia and depression are both frequently triggered by
environmental stressors, such as psychological stress or trauma
[15e17]. DNA methylation is an epigenetic mechanism that allows
interaction between gene expression and the environment. The
role of the epigenetic regulation of sleep and emotions is
emerging, and changes in DNA methylation have been linked to
different forms of depression as well as to antidepressant response
[18]. Furthermore, altered expression of histone deacetylases,
major methylating enzymes, was found in depressive states, but
not after remission, suggesting that methylation-driven changes in
gene expression can play a role in the pathophysiology of
depression [19]. In mice, sleep deprivation causes markedLoca?on 
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Fig. 1. The study protocol. Exclusion criteria were: mental retardation, chronic somatic illne
years, insufﬁcient knowledge of Finnish language, principal Diagnostic and Statistical Manua
and any contraindications for brain Magnetic Resonance Imaging (MRI). Timeline between
which was done directly after PSG.
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genes involved in synaptic plasticity, and concordant RNA
expression changes [20]. These methylation changes are possibly
driven by LTP, a major component in synaptic plasticity [21].
Additionally, in young healthy men, total sleep deprivation caused
marked changes in the methylation of white blood cells and RNA
expression [20]. In a large cohort of older women, insomnia
symptoms, but not shortened sleep, were associated with altered
methylation of peripheral blood leukocytes [22].
Given the systemic physiological effects of sleep insufﬁciency
and depression, we hypothesized that sleep difﬁculties and
depression have an effect on DNA methylation in peripheral blood
leukocytes. To our knowledge, no studies in human clinical samples
exist concerning the effect of sleep disturbances and depression on
DNA methylation. We studied this in a sample of depressed ado-
lescents with sleep difﬁculties compared to age- and gender-
matched controls. We were particularly interested in identifying
deviating patterns of DNA methylation in genes from pathways
related to disturbed sleep. Finally, given the impact of sleep difﬁ-
culties on depression in the short and long term, we hypothesized
that sleep difﬁculties could show an effect on DNAmethylation that
is not entirely explained by depression severity.
2. Methods
2.1. Subjects
A total of 20 non-medicated adolescent boys aged 14.70e17.40
years (mean 16.05 years) participated in this study. Ten were cases
all suffering from depressive and sleep symptoms recruited from
the Helsinki University Central Hospital Department of Adolescent
Psychiatry outpatient units, while 10 were healthy controls
recruited via advertisements in a newspaper for the hospital staff.
Due to dropout, genetic blood samples were not available for two
subjects in the case group and one subject in the control group,
leaving a total of 17 subjects in the analyses presented in this paper.
The adolescents took part in a larger research project focusing on
adolescent depression, sleep and brain maturation (the ADSLEEP
project) [23e25]. Both the subjects and their parents or legal
guardians gave written informed consent for participating in the
study, and the study protocol (Fig. 1) was approved by the ethics
committee of the Helsinki University Central Hospital.
Exclusion criteria for all subjects included mental retardation,
chronic somatic illness, current use of medication, substance abuse/
dependence, age over 17.5 or under 14.5 years, insufﬁcient     Adolescent´s home 
2 consecu?ve 
nights 
Outpa?ent/research unit 
1 visit directly a?er PSG 
Psychomotor 
vigilance task 
 
ple Polysomnography 
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ss, current use of medication, substance abuse/dependence, age over 17.5 or under 14.5
l of Mental Disorders, fourth Edition (DSM-IV) diagnosis other than depressive disorder,
different study events varied from case to case, except for Psychomotor vigilance task,
nes related to synaptic long-term depression among adolescents with
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Manual of Mental Disorders, fourth Edition (DSM-IV) diagnosis
other than depressive disorder, and any contraindications for brain
magnetic resonance imaging (MRI). All subjects remained free of
psychotropic and other medications during the entire study period.
The presence of somatic conditions was ruled out based on blood
samples, which included measurements of blood cell count, serum
testosterone, serum luteinizing hormone, C-reactive protein, fasted
blood sugar levels, and liver, kidney and thyroid function mea-
surements. No structural pathologies were found in their brain
anatomy according to brain MRI evaluated by a neuroradiologist.
The subgroups of cases and controls did not differ in terms of their
age, body mass index (BMI), or serum testosterone levels (inde-
pendent samples t-tests p > 0.05; Table 1). All subjects consumed
less than three cups of coffee daily (or the equivalent amount of
other caffeinated products). Subject characteristics are described in
detail in Supplementary Table S1.2.2. Psychiatric evaluation
The present and lifetime episodes of DSM-IV axis I disorders
were assessed with a semi-structured diagnostic interview, the
Schedule for Affective Disorders and Schizophrenia for School-Age
Children: Present and Lifetime version (K-SADS-PL) [26]. The same
clinician (A.S.U.) performed all of the interviews, and the diagnoses
were conﬁrmed in a diagnostic meeting with a senior clinician
(M.M.). No axis I diagnoses were found among the controls. The
cases were conﬁrmed to suffer from depressive disorder (lifetime
ﬁrst depressive episode for six, second episode for one of the cases;
mean length of the current depressive episode at the time of
interview, 58 ± 53 weeks), except for one case who only suffered
from a circadian rhythm sleep disorder with minor mood symp-
toms (pessimistic views of the future, feelings of failure, disap-
pointment in oneself, self-criticism, fatigue). None of the cases
manifested psychotic features or suffered from bipolar disorder.Table 1
Sample characteristics presented for the total sample (N ¼ 17), and separately for the ca
Variable
Age (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
BMI (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
S-Testo (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
BDI-21 (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
GAF (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
AIS (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
PDSS (N ¼ 16)
Cases (N ¼ 7)
Controls (N ¼ 9)
TST (N ¼ 17)
Cases (N ¼ 8)
Controls (N ¼ 9)
AIS, Athens Insomnia Scale; BDI-21, 21-item Beck Depression Inventory; BMI, body m
Sleepiness Scale; S-Testo, serum testosterone level (nmol/L); SD, standard deviation; TST
a Statistically signiﬁcant differences between the cases and controls at a statistical thr
b Statistically signiﬁcant differences between the cases and controls at a threshold of
Please cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
depressive disorder and sleep symptoms, Sleep Medicine, https://doi.orgThe majority of cases (6/8) did not have comorbid axis I disorders.
Comorbid anxiety disorder was present in one case and comorbid
disruptive behaviour disorder in another.
As part of the DSM-IV axial diagnostic procedure, the global
assessment of functioning scale (GAF; numeric range of 0e100) was
used according to DSM-IV guidelines to assess overall psychosocial
functioning [6]. GAF has previously been used in studies among
adolescents [27,28].
Depression symptom severity was assessed with the 21-item
Beck Depression Inventory (BDI-21), a standardized 21-item self-
rating questionnaire [29] which has been well studied in adoles-
cents [30,31]. In the BDI-21, subjects are asked to rate each of the
symptoms on a four-point scale (range 0e3) according to the
severity of the symptom (sum score range 0e63). In correlation
analyses with differentially methylated positions (DMPs), a shorter
version of the BDI, excluding the sleep and tiredness items, anno-
tated here as BDI-19 (sum score range 0e57), was applied.2.3. Psychomotor vigilance task
The psychomotor vigilance task (PVT) is a widely used neuro-
behavioural test to assess sustained attention [32]. As part of a
larger neuropsychological test battery, a 5-min version of the PVT
task was performed with a PVT-192 unit (Ambulatory Monitoring,
Inc., Ardsley, NY, USA). During the task, a digital millisecond
counter starts to scroll on a small computer screen at random in-
tervals of 2e10 s, and the subjects have to respond by pressing a
button as quickly as possible to stop the counter. After each press,
immediate feedback on performance is displayed on the screen.
The tests that differed between cases and controls (p < 0.05,
one-way analysis of variance (ANOVA)) were median reaction time
(Median RT) (p ¼ 0.022), minimum reaction time (MIN RT)
(p ¼ 0.007) and fastest 10% mean reaction time (FRT) (p ¼ 0.010).
We chose Median RT to represent vigilance in the secondary
analysis.ses (N ¼ 8) and controls (N ¼ 9).
Mean SD Range
16.05 0.80 14.70e17.40
15.93 0.86 14.70e17.30
16.16 0.78 14.80e17.40
21.22 2.77 16.78e27.55
21.89 3.58 16.78e27.55
20.62 1.83 17.82e23.80
19.79 3.77 15.00e27.60
20.28 4.12 15.00e26.30
19.36 3.63 15.30e27.60
9.65 11.05 0e33
17.63a 11.05 6e33
2.56a 4.16 0e12
66.76 16.57 43e90
50.62b 6.16 43e59
81.11b 4.86 75e90
6.12 6.11 0e18
10.75b 5.75 1e18
2.00b 2.29 0e7
15.94 6.07 6e26
19.71a 5.35 12e26
13.00a 5.05 6e21
454.35 69.10 312.5e529.5
412.31a 82.22 312.5e517.0
491.72a 17.21 469.0e529.5
ass index; GAF, Global Assessment of Functioning Scale; PDSS, Pediatric Daytime
, total sleep time (min). In bold both groups combined.
eshold of p < 0.05.
p < 0.001 (independent samples t-tests).
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The sleep symptoms were assessed as part of the K-SADS-PL
interview attachment for affective disorders, which contains six
items on sleep (initial insomnia, middle insomnia, terminal
insomnia, sleepewake rhythm disturbance, non-restorative sleep,
and hypersomnia). The interviewer rates each symptom as non-
existent, sub-threshold, or clinically signiﬁcant according to stan-
dard criteria, explained in detail previously [33]. The patients'
clinically signiﬁcant sleep symptoms are listed in Supplementary
Table S1. No clinically signiﬁcant sleep symptoms were found
among the controls.
The Athens Insomnia Scale (AIS) was used to assess insomnia
symptoms during the past month based on International Classiﬁ-
cation of Diseases 10th edition (ICD-10) criteria [34]. The AIS is a
validated self-report questionnaire consisting of eight items rated
on a scale of 0e3 (total sum score range 0e24) on sleep induction,
awakenings during the night, ﬁnal awakening, total sleep duration,
sleep quality, daytime well-being, daytime functioning capacity
and sleepiness during the day.
The Pediatric Daytime Sleepiness Scale (PDSS) was used to
measure daytime sleepiness [35]. The PDSS is a self-rated sleepi-
ness scale specially designed for use among school-aged adoles-
cents. It consists of eight items rated on a scale of 0e4 (total sum
score range 0e32) related to daytime alertness, daytime tiredness/
grumpiness, trouble waking up, frequency of falling asleep/
drowsiness in class and while doing homework, falling back to
sleep after being awakened, need for outside help to wake up and
thoughts of needing more sleep.
Sleep architecture was measured with polysomnography
including electroencephalogram (EEG), electrooculogram (EOG)
and chin electromyogram (EMG) recordings. Polysomnographywas
performed in the adolescents' home environment using portable
recording devices (Embla, Flaga Hf. Medical devices, Reykjavik,
Iceland; EEG derivations F4-M1, C4-M1, O2-M1 and backup deri-
vations F3-M2, C3-M2, and O1-M2; sampling rate 200 Hz). The
electrode positions were determined according to the International
10e20 system. Polysomnography was performed for two consec-
utive nights and, for the purposes of this study, the ﬁrst night
(adaptation night) was discarded and the second night of poly-
somnography was used in the analyses. One of the most important
functional parameters of the sleeping EEG, slow wave sleep (SWA),
was calculated using a power spectral analysis according to a pre-
viously described procedure [23]. Because in previous work with
the same sample of adolescents we detected a ﬂattening of SWA
dissipation associated with depression especially in the frontal
electrodes [23], we also wanted to explore its effect on methylation
in this study.2.5. Epigenetic analyses
Blood samples were obtained from peripheral venous sampling
and DNA was extracted according to standard laboratory methods.
The blood samples were taken at varying intervals from the clinical
measurements (average time between clinical interview and blood
sampling was 25 days ± 51; range 3e218 days), but since the same
investigator also conducted the post-sampling procedures (A.S.U.)
and there were no apparent changes in the clinical status of the
cases and controls, we can assume that they were symptomatic or
asymptomatic, respectively. For depressed cases, the average time
between the beginning of depression episode and blood sampling
was 415 days (range 78e1078 days; standard deviation (SD) ± 377
days). We therefore explored the association between time spent
depressed and level of methylation for those loci of special interest.Please cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
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DNA was bisulﬁde converted with the EZ-methylation kit
(ZYMO research, Irvine, CA, USA). Bisulﬁte-converted DNAwas then
analysed with the Illumina Inﬁnium HumanMethylation450
BeadChip Kit (Illumina Inc., San Diego, CA, USA) at the Estonian
Genome Center. Quality control (QC) was performed using R soft-
ware (R  3.0.1) with speciﬁc algorithms implemented in R pack-
ages ‘minﬁ’, ‘IlluminaHumanMethylation450kmanifest’ and
‘limma’ [36]. At this stage, probes with a detection of p > 0.01 for
any DNA sample or those missing measurements, known as cross-
reactive probes, probes on X and Y chromosomes, and probes that
contained either a single nucleotide polymorphism (SNP) at the
CpG interrogation site or at the single nucleotide extension were
excluded from subsequent analysis. Altogether, 46,384 probes were
excluded, leaving 439,128 probes for subsequent analysis.
Normalization of the 450K data was performed using the subset-
quantile within-array normalization (SWAN) function in R-pack-
age ‘minﬁ’, which takes into account the fact that the Illumina 450k
chip uses two types of assays [37,38] with two different types of
chemistry, making different probes comparable to each other. We
calculated estimates for white blood cell populations of each
samplewith ‘limma’ and compared estimated populations for cases
and controls with t-tests (Supplementary Table S2) [39,40]. No
signiﬁcant differences (p < 0.05) were found in cell population
distributions between cases and controls. All raw values in 450K
were then converted to M-values in order to take into account the
non-linear Bernoulli-type distribution of the raw values in the
array, which creates biased methylation values, especially at highly
methylated probes [41]. The M-value is calculated as the log2 ratio
of the intensities of amethylated probe versus unmethylated probe,
and describes a measurement of how much more a probe is
methylated than unmethylated. A positive M-value, hence, means
that more than half of a probe is methylated. M-values were then
used in data analysis.
3. Statistical analyses
3.1. Genome-wide analysis of DNA methylation in cases compared
to controls
In genome-wide analysis of the data from the Illumina 450K
chip, we used an empirical Bayes moderated t-test in probe-wise
comparisons to compare the methylation values between cases
and controls and to thereby identify DMPs. This approach was used
because it is especially well-suited for experiments with a small
number of arrays and for both one- and two-channel microarray
experiments, such as the Illumina 450K [42]. To correct for multiple
testing, we used the BenjaminieHochberg procedure (BH) in R-
package ‘limma’ [43], which is based on false discovery rate (FDR)
calculations using a p < 0.05 cut-off. We set genome-wide signiﬁ-
cance to 5.0  108 [36].
3.2. Pathway analysis
The 500 sites that differed the most between cases and controls
according to the genome-wide analysis were entered into Ingenuity
PathwayAnalysis (IPA; Ingenuity Systems, RedwoodCity, CA, USA) to
assess the biological relevance of dysregulated DMPs in cases
compared to controls. This threshold was chosen to yield a
manageable number of sites for pathway analysis. After removing
sites that did not pass the QC procedure described above, therewere
486 sites remaining. Of those sites, IPA could annotate 332 to a
known gene in its pathway repository. A list of those genes is shown
in Supplementary Table S3. IPA compares a given set of genes tones related to synaptic long-term depression among adolescents with
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Fisher's exact test to evaluate whether this gene set is enriched to
some pathway more than would be expected by chance. It does not
correct formultiple testing, but correction formultiple testingwould
only affect themagnitude of a detected p-value, not which pathways
arise from the analysis or the order of pathways.
Our top canonical pathway was the synaptic LTD pathway
(p ¼ 0.00045) followed by the Nitric Oxide Signaling pathway
(NOS) signalling in skeletal muscle cells pathway and netrin sig-
nalling pathway both with nearly 10-fold higher p-value
(p ¼ 0.0042). All p-values are nominal.
A canonical pathway refers to a molecular pathway that is an
idealized or generalized pathway representing common properties
of a module or pathway [44]. We chose to continue with canonical
pathways as they are the most generalizable across species and
tissues and are considered to be the most common pathways of a
module or pathway.
3.3. Correlation between methylation and depression, indices of
sleep and neuropsychological performance
We used linear regression between methylation and mood,
tiredness and sleep, and neuropsychological measurements. Since
original caseecontrol status was expected to have an effect on re-
sults in these secondary analyses, we denoted whether the asso-
ciation was also signiﬁcant after controlling for the caseecontrol
status by including the status as a covariate in the analysis. In
addition, we denoted whether the association survived Bonferroni
correction for multiple testing. All analyses were performed using
SPSS v.24 (IBM, Armonk, NY, USA).
4. Results
4.1. Epigenome-wide analysis between cases and controls
We ﬁrst compared the genome-wide DNA methylation levels of
depressed adolescents with healthy controls using the Illumina
450K array. There were no genome-wide signiﬁcant differences in
methylation levels between cases and controls (all p > 5  108).
Next, we proceeded to pathway analysis by including 500 sites
that differed most in cases vs controls upon initial analysis,
comprising 332 sites that annotated to a known gene. Our top ca-
nonical pathway was the synaptic LTD pathway (10/165 sites)
(p ¼ 0.00045), followed by the NOS signalling in skeletal muscle
cells pathway and Netrin signalling pathway, both with a nearly 10-
fold higher p-value (p ¼ 0.0042).
Sites in the LTD pathway that were present in the top 500 DMPs
were cg16841761 at Calcium Voltage-Gated Channel AuxiliaryTable 2
Relative methylation status of long-term depression pathway methylation sites that appe
the genome-wide analysis their respective genes, and values in cases and controls.
Locus Gene p-value in 450K array Methy
cg1684176 CACNG1 0.000381 Lower
cg22025854 CACNG6 0.000527 Highe
cg08364956 GRM6 0.000838 Lower
cg05110803 IGF1R 0.000306 Lower
cg19161850 ERK12 0.000663 Highe
cg12066398 PLA2G16 0.000540 Highe
cg04367351 PLA2R1 0.000659 Highe
cg02263165 PPP2R5C 0.000207 Highe
cg18823846 PRKG1 0.000903 Highe
cg25405123 RYR3 0.000427 Highe
a ‘Lower’ indicates that methylation at the CpG site is lower in cases vs controls and ‘
b M-values indicate normalized methylation values.
Please cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
depressive disorder and sleep symptoms, Sleep Medicine, https://doi.orgSubunit Gamma 1 (CACNG1), cg22025854 at CalciumVoltage-Gated
Channel Auxiliary Subunit Gamma 6 (CACNG6), cg08364956 at a
heterochromatic area of Glutamate Receptor, Metabotropic 6
(GRM6), cg05110803 at a weak enhancer region of the Insulin Like
Growth Factor 1 (IGF1R), cg19161850 at a promoter region of the
gene encoding for Extracellular Signal-Regulated Kinase 1 and 2
(ERK12) (also known as Mitogen-Activated Protein Kinase 1,
MAPK1), cg12066398 at a promoter region of Phospholipase A2
Group XVI (PLA2G16), cg04367351 at Phospholipase A2 Receptor 1
(PLA2R1), cg02263165 at a promoter region and downstream
transcription start site of Protein Phosphatase 2 Regulatory Subunit
‘B’ gamma’ (PPP2R5C), cg18823846 at Protein Kinase, CGMP-
Dependent, Type I (PRKG1) and cg25405123 at a bivalent pro-
moter region of Ryanodine Receptor 3 (RYR3).
Among these sites, DMPs at GRM6, CACNG1 and IGF1R showed
lower, and all other sites higher, levels of methylation in cases
compared to controls (relative hypo- and hypermethylation,
respectively) (Table 2).4.2. Secondary analysis with three domains and methylation of
sites related to the LTD pathway
Given overall statistical evidence from the pathway analysis and
previous evidence on the intimate connection between sleep,
mood and cognition [45,46], we focused the secondary analysis on
the DMPs identiﬁed from the LTD pathway.
Secondary analyses utilized linear regression to model associa-
tions between the 10 methylation loci for the LTD pathway and the
subjective and objective measures for depressed mood (BDI-19),
tiredness (PDSS) and vigilance (median RT), and sleep (AIS, SWA
dissipation) in the whole sample. Since only one site, cg12066398
(PLA2G16), showed correlation between methylation and depres-
sion length (b ¼ 0.860, p ¼ 0.013 uncorrected for multiple testing),
we decided not to adjust analyses by depression length. Adjusting
would have abolished controls from the analysis, leaving the
sample size very low (Table 3).
In linear regression models with no covariates, we found asso-
ciations between mood (BDI-19) and PLA2G16 (b ¼ 0.77,
p ¼ 0.00031) and with tiredness (PDSS) and IGF1R (b ¼ 0.79,
p ¼ 0.00029), ERK 12 (b ¼ 0.72, p ¼ 0.002) and PLA2R1 (b ¼ 0.77,
p ¼ 0.00047). We also found an association with sleep (AIS) and
RYR3 (b ¼ 0.76, p ¼ 0.00041). Finally, we found an association be-
tween PPP2R5C and SWA dissipation (b ¼  0.67, p ¼ 0.004). Of
these, results from PLA2G16, IGF1R, PLA2R1 and RYR3 survived
Bonferroni correction (Table 3).
In linear regression models where original caseecontrol status
was taken into account as a covariate, we found several nominal
associations between certain sites and parameters. Nominalared in the 500 sites that differed the most between cases and controls according to
lation level in cases vs controlsa Average M-valueb for cases/controls
3.18/3.49
r 1.17/1.57
3.29/3.56
1.47/1.95
r 3.88/4.13
r 3.70/4.07
r 4.14/4.46
r 3.14/3.35
r 3.95/4.20
r 3.61/3.89
higher’ means higher methylation in cases vs controls.
nes related to synaptic long-term depression among adolescents with
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Table 3
Linear regression results between long-term depression pathway methylation sites and mood, vigilance and tiredness, and sleep.
Locus (gene) Mood Vigilance and
tiredness
Sleep
BDI-19 Median RT PDSS AIS SWAdiss
В p В p В p В p В p
cg1684176 (CACNG1) 0.69 0.002 0.44 0.08 0.58 0.02 0.68 0.003 0.38 0.14
cg22025854 (CACNG6) 0.44 0.08 0.40 0.11 0.19 0.49 0.55 0.02 0.25 0.36
cg08364956 (GRM6) 0.47 0.06 0.26 0.31 0.60 0.01 0.75 0.001 0.38 0.15
cg05110803 (IGF1R) 0.50 0.04 0.28 0.29 0.79 0.00029a,b 0.68 0.003 0.24 0.38
cg19161850(ERK 12) 0.55 0.023 0.21 0.43 0.72 0.002a 0.65 0.005 0.47 0.67
cg12066398 (PLA2G16) 0.77 0.00031b,a 0.66 0.004 0.33 0.21 0.70 0.002 0.32 0.23
cg04367351(PLA2R1) 0.48 0.053 0.17 0.51 0.77 0.00047a,b 0.68 0.003 0.30 0.26
cg02263165 (PPP2R5C) 0.64 0.006 0.51 0.035 0.32 0.23 0.65 0.005 0.67 0.004a
cg18823846 (PRKG1) 0.57 0.018 0.49 0.045 0.50 0.051 0.60 0.010 0.16 0.56
cg25405123 (RYR) 0.64 0.006 0.42 0.095 0.44 0.091 0.76 0.00041b 0.54 0.031
AIS, Athens Insomnia Scale; BDI-19, Beck Depression Inventory with questions concerning sleep and tiredness removed; Median RT, median reaction time in psychomotor
vigilance task (PVT); PDSS, Pediatric Sleepiness Scale; SWAdiss, slow wave dissipation during ﬁrst episode of the night measured from frontal electrodes.
a Association is signiﬁcant at <0.05 level when caseecontrol status is controlled for (nominal).
b Association is signiﬁcant after Bonferroni-correction.
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observed for cg05110803 (from IGF1R), cg19161850 (ERK 12) and
cg04367351 (PLA2R1) to subjective tiredness (p ¼ 0.007, 0.041 and
0.011, respectively), cg12066398 (PLA2G16) to depressed mood
(p ¼ 0.031) and cg02263165 (PPP2R5C) to slower SWA dissipation
(p ¼ 0.02) (Table 3, Fig. 2(a)e(e)).
Although the statistical signiﬁcance was limited due to small
sample size, these ﬁndings make biologic sense, with similar trends
observed for both cases and controls. For example, lower methyl-
ation levels at cg05110803 (IGF1R), which showed relative hypo-
methylation in cases compared to controls in the initial
caseecontrol analysis, also associated with more pronounced
tiredness in both cases and controls (Fig. 2(a)). Similarly, higher
methylation levels at cg02263165 (PPP2R5C), which showed rela-
tive hypermethylation in cases in the initial analysis, associated
with slower SWA dissipation among both cases and controls
(Fig. 2(c)).
5. Discussion
In this study we searched for deviating methylation patterns in
adolescents with depressive disorder and sleep difﬁculties, as
compared to age- and gender-matched controls. Due to small
sample size, this was aimed as a hypothesis-generating rather than
hypothesis-conﬁrming study. However, we found enrichment of
DMPs at genes from a canonical pathway essential for learning and
memory consolidation, the synaptic LTD pathway. This ﬁnding adds
to the systematic evidence of the connection between depressive
disorder, sleep and cognition, and supports earlier results con-
cerning the role of sleep in synaptic plasticity, especially during
brain development [46].
LTD acts in memory consolidation and synaptic plasticity
together with long-term potentiation. LTD can deactivate mem-
ories that are activated by LTP and, thus, learning can be seen as a
result of a balance between these two processes [47]. LTD also plays
a crucial role in the formation of new memories [48]. Sleep depri-
vation can signiﬁcantly increase LTD in rat hippocampus [49], and
the possiblemechanism could be related to an altered expression of
g-aminobutyric acid (GABA) B receptors [50].
It is postulated that the decrease in SWA during the course of
sleep is associated with reduced synaptic strength and is thus
related to memory consolidation [51]. Our previous results on the
same sample of adolescents indicated that this SWA dissipation
that occurs normally during healthy sleep is affected by depressionPlease cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
depressive disorder and sleep symptoms, Sleep Medicine, https://doi.organd related sleep disturbances [23]. The results of the current study
further propose a link between SWA dissipation and changes in
methylation of the Protein Phosphatase 2 regulatory subunit
B'gamma (PPP2RC5).
According to an epigenome consortium [52], certain tissues
have commonmethylation patterns across each other, while others
do not. With the Epigenome browser (http://epigenomegateway.
wustl.edu/browser/) (WashU), we explored methylation values
and expression levels of PPP2R5C's cg12066398, located at chro-
mosome 14; 102,276,300. It appeared that methylation levels of
different histone methylation arrays were comparable between
peripheral blood leukocytes and brain hippocampal cells, but no
data concerning CpG methylation was available from brain tissue
and peripheral blood leukocytes for comparison.
PPP2R5C belongs to the phosphatase 2A regulatory subunit B
family. This phosphatizing enzyme is implicated in the negative
control of cell growth and division (RefSeq, Jul 2008). Mutations in
this enzyme family are related to human overgrowth syndromes
accompanied by intellectual disabilities [53]. This family of en-
zymes is highly and widely expressed in the human brain [54].
Protein phosphatases are responsible for the induction of LTD and
initiating the cascadewith a slow Caþ ion ﬂow into neurons [55,56].
We found that those patients with the highest levels of methylation
in the promotor region of PPP2R5C, suggesting slower LTD induc-
tion, also had the ﬂattest SWA dissipation pattern throughout the
night. The association between methylation and gene expression
can either be active, where methylation directly affects gene
expression, or passive, meaning that methylation is just a by-
product of expression regulation. Either way, it can be regarded
as an indicator of gene expression regulation [57,58]. It has also
been shown that even small changes in DNA methylation may
result in marked differences in phenotype [59].
The other genes of the LTD pathway found to correlate with
sleep and depression in the current study were ERK12, PLA2G16,
IG1FR and PLA2R1. Extracellular signal-regulated kinase (ERK) is a
group of protein kinases that belong to a larger family of mitogen-
activated protein kinases (MAPK). ERK12 is related to the formation
of LTP and is partially regulated by phosphatases, such as PPP2R5C
[60,61]. Notably, we found correlation between daytime sleepiness
and ERK12, which is in line with ﬁndings that this enzyme is
involved in the daytime enhancement of LTP [62]. There is evidence
that for synaptic plasticity, LTP is favoured during the daytime and
contributes to the strengthening of synapses, whereas LTD is
induced by slow wave sleep (SWS) [62]. This creates a balancenes related to synaptic long-term depression among adolescents with
/10.1016/j.sleep.2019.01.050
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Fig. 2. a. Correlation between methylation of cg05110803 (IGF1R) and tiredness (Pediatric Daytime Sleepiness Scale, PDSS) (b ¼ 0.79, p ¼ 0.00029.) b. Correlation between
methylation of cg19161850 (ERK12) and tiredness (Pediatric Daytime Sleepiness, PDSS) (b ¼ 0.72, p ¼ 0.002). c. Correlation between cg12066398 (PLA2G16) methylation and
depression (Beck Depression inventory with questions concerning sleep and tiredness removed, BDI-19) (b ¼ 0.77, p ¼ 0.00031). d. Correlation between cg02263165 (PPP2R5C)
methylation and slow wave dissipation (SWAdiss) during ﬁrst episode of the night measured from frontal electrodes (b ¼ 0.67, p ¼ 0.004). e. Correlation between methylation of
cg04367351 (PLA2R1) and tiredness (Pediatric Daytime Sleepiness, PDSS) (b ¼ 0.77, p ¼ 0.00047).
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weakening, allowing new information to be consolidated while
preserving previous information. PLA2G16 (Phospholipase A2
Group XVI) mediates the ERK12 pathway [63]. IGF1R (Insulin-like
Growth Factor 1 Receptor) is a protein coding gene that plays a
crucial role in central nervous system (CNS) development, matu-
ration and neuronal plasticity [64]. Blocking IGF1R in mouse Pur-
kinje cells leads to cessation of LTD [65]. PLA2R1 (Phospholipase A2
Receptor 1) is a protein-coding gene that has a variety of roles
depending on tissue. Its role in LTD is somewhat unclear, but it is
identiﬁed as a part of both pre- and postsynaptic cascades related
to regulation of LTD and is activated by ERK 12. Neuronal activity
during SWS has been shown to promote LTD in neurons [47,51], andPlease cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
depressive disorder and sleep symptoms, Sleep Medicine, https://doi.orgthe slow oscillation that happens in neurons during SWS favours
LTD over LTP [48], suggesting that the SWS stage is strongly related
to LTD. In contrast, other sleep stages, especially REM sleep, have a
stronger effect on LTP [56]. Different sleep disturbances can
therefore affect LTP and LTD differently [56,66]. Since in our sample
there was no marked difference in REM sleep between cases and
controls [23], it is plausible that there were no differences in LTP
genetic pathways either.
We did not ﬁnd marked differences in cognitive performance
between cases and controls (unpublished data), except for a longer
mean reaction time, minimum reaction time, and fastest 10% re-
action time in cases vs controls, implying lower vigilance among
cases. This is in line with previous studies concerning the effect ofnes related to synaptic long-term depression among adolescents with
/10.1016/j.sleep.2019.01.050
A.-J. €Amm€al€a et al. / Sleep Medicine xxx (xxxx) xxx8depression on adolescent cognitive performance [65] and the effect
of sleep difﬁculties on cognition [67]. This is somewhat in contrast
to ﬁndings in adults, however, putatively reﬂecting the speciﬁc
developmental stage involving marked changes in the reorganizing
of neural networks (synaptic pruning) and consolidation of cortical
neural layers [68,69]. Given the variable but, on average, quite long
duration of depressive disorder (mean length from beginning of
episode to sampling: 415 ± 377 weeks), the cases in our sample
may have been able to compensate for the effect of depression and
sleep disturbance on cognition. Although the changes in methyl-
ation of the LTD pathway would suggest compromised synaptic
plasticity, it is thus possible that altered epigenetic regulation of the
LTD pathway is a compensatory mechanism for changes in SWA
dissipation, acting to protect individuals from memory and other
cognitive impairments during adolescence.
The strengths of the study include the carefully selected and
homogeneous sample: all participants were boys, they were all
non-medicated, the age range of the sample was narrow, and the
participants underwent careful clinical assessment. Further, the use
of polysomnography to objectively assess sleep is also one of the
major strengths of the study. An evident shortcoming in our study
includes the small sample size. Because of this, we were unable to
conduct reliable analyses for possible methylation quantitative loci
(mQTLs). mQTLs are SNPs that can have an effect on the methyl-
ation of one or several distant CpG sites. Thus, the results need to be
duplicated and extended in larger samples before more extensive
interpretation.
We did not adjust analyses for depression length but, based on
our analyses, that would lead to exploration of cases only and thus
an even more limited sample size. All participants remained free
from psychotropic and other medication during the study period.
The patients received, however, ‘treatment as usual’ at the Helsinki
University Hospital adolescent psychiatric outpatient unit, which
usually consists of individual (frequency typically once a week) and
family appointments (frequency typically once a month) and thus
we cannot rule out the effect of psychosocial treatment on the
ﬁndings from the secondary analysis. We analysed epigenetic al-
terations from peripheral blood leukocytes, and it is known that
many epigenetic alterations are tissue speciﬁc [52]. It is not, how-
ever, an easy task to obtain living brain tissue for epigenetic studies.
Peripheral blood leukocytes serve as a good option to study sleep-
related changes in the CNS since the brain's lymphatic drainage
system connects the immune system, CNS and sleep tightly
together [70]. Therefore, it is exciting that we found an association
between sleep and methylation of the LTD pathway. Some data-
bases exist where the methylation level of peripheral blood leu-
kocytes and brain tissues can be found (eg, Epigenome browser),
but they do not cover all sites or all methylation arrays. Moreover,
comparable samples from the same individual, drawn at the same
time point, do not exist, making comparison even more uncertain
[71]. Further, only boys were included in our sample, limiting the
generalizability of the ﬁndings to girls.
Our Pathway analysis did not correct for multiple testing, but
correctionwould not changewhich pathways arise as most likely to
associate with a set of genes derived from DMPs. This approach
allows the generation of a new hypothesis concerning the interplay
between sleep, depression and cognition.
In conclusion, our work presents new insights into the sys-
tematic effects of disordered sleep and depression, resulting in a
deviating pattern of DNA methylation in blood leukocytes and
providing evidence of compromised synaptic plasticity among a
group of adolescents with depressive disorder and disturbed sleep.
However, further studies involving more detailed neurobiological
analysis in both experimental and naturalistic settings should be
conducted in order to further explore the link between systematicPlease cite this article as: €Amm€al€a A-J et al., Epigenetic dysregulation of ge
depressive disorder and sleep symptoms, Sleep Medicine, https://doi.organd brain-speciﬁc epigenetic modiﬁcations of LTD pathway genes
and their relationships with depression and disordered sleep.
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